Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-24

FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for palonosetron hydrochloride submitted by Sagent Pharmaceuticals to support an approved indication/label update for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

SUPPL AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)